Skip to main content

Table 2 VEGF polymorphisms in gastrointestinal cancer cell lines

From: Biomarkers for antitumor activity of bevacizumab in gastric cancer models

 

Genotype

 

Polymorphic site

Cell line

-2578

-1154

-634

936

MKN-45

A/A

A/A

G/G

T/T

4-1ST

C/A

G/A

G/G

C/C

GXF97

C/A

G/A

C/G

C/C

MKN-28

C/C

G/A

C/C

C/C

SC-09-JCK

C/C

G/A

G/G

C/C

SC-08-JCK

C/C

G/A

C/C

T/T

NCI-N87

C/A

G/A

G/G

C/C

SC-10-JCK

C/A

G/A

G/G

C/T

SCH

C/C

G/A

C/G

C/C

  1. VEGF polymorphisms (-2578, -1154, -634 and 936 on VEGF genomic DNA) were examined by using LightCycler™